FF
GILD icon

FourThought Financial’s Gilead Sciences GILD Stock Holding History

FourThought Financial’s Portfolio GILD Stock Details GILD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		$76K Sell
1,231
-225
-15% -$14.2K 0.01% 497
2022
Q2 		$90K Sell
1,456
-445
-23% -$27.6K 0.01% 465
2022
Q1 		$113K Sell
1,901
-339
-15% -$21.7K 0.01% 450
2021
Q4 		$163K Sell
2,240
-659
-23% -$45.4K 0.02% 374
2021
Q3 		$202K Sell
2,899
-692
-19% -$48.6K 0.03% 337
2021
Q2 		$247K Sell
3,591
-3,253
-48% -$217K 0.03% 318
2021
Q1 		$442K Sell
6,844
-1,083
-14% -$69.8K 0.06% 230
2020
Q4 		$461K Buy
+7,927
New +$478K 0.07% 210

Other funds holding GILD

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

FourThought Financial's GILD Position: Q3 2022 in Review

FourThought Financial reduced its Gilead Sciences (GILD) stake by 15% in Q3 2022, selling an estimated $14.2K and leaving 1,231 shares worth $76K. The position accounts for 0.01% of the portfolio, ranked #497.

FourThought Financial first reported a position in GILD in Q4 2020 and has held it in 8 quarters since. The position peaked at $461K in Q4 2020. 1,603 funds tracked by Wall St. Rank hold GILD as of Q3 2022.

  • FourThought Financial held 1,231 shares of Gilead Sciences worth $76K as of Q3 2022.
  • FourThought Financial sold 225 Gilead Sciences shares in Q3 2022, an estimated $14.2K.
  • Gilead Sciences made up 0.01% of FourThought Financial's portfolio in Q3 2022, its #497 holding.
  • FourThought Financial first reported a position in Gilead Sciences in Q4 2020 and has held it in 8 quarters since.
  • FourThought Financial's Gilead Sciences position peaked at $461K in Q4 2020.
  • 1,603 funds tracked by Wall St. Rank held Gilead Sciences as of Q3 2022.

Based on FourThought Financial's 13F filing for Q3 2022, filed 21 Nov 2022.